APhaD mission is to provide our Clients and Partners with solutions for early ADMET, formulations, analysis and bio-analysis in drug development. APhaD is offering a battery of ADMET assays to support Customers in better characterizing their compounds and identifying cost effective profiling strategies. An expert data interpretation is included in the service ensuring maximum delivery and value for the Customers. APhaD team is also focused on offering its Customers with a variety of classical and tailored analyses providing high quality data based on rigorous protocols. APhaD is authorized to carry out tests in compliance with GLP for 1) Physical-chemical testing, 6) Residues studies and 9.7) Pharmacokinetics/toxicokinetics and ADME studies. APhaD is certified to work in compliance with GCP for bio-analysis in human clinical studies (PK, BA/BE). AIFA (Italian Medicines Agency) has recorded APhad in the the National Monitoring Centre for Clinical Trials (OsSC).